These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 32527232)

  • 1. Safety and efficacy of glibenclamide combined with rtPA in acute cerebral ischemia with occlusion/stenosis of anterior circulation (SE-GRACE): study protocol for a randomized controlled trial.
    Huang K; Ji Z; Wu Y; Huang Y; Li G; Zhou S; Yang Z; Huang W; Yang G; Weng G; Chen P; Pan S
    BMC Neurol; 2020 Jun; 20(1):239. PubMed ID: 32527232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and efficacy of glibenclamide combined with rtPA in acute cerebral ischemia with occlusion/stenosis of anterior circulation (SE-GRACE): a randomized, double-blind, placebo-controlled trial.
    Huang K; Zhao X; Zhao Y; Yang G; Zhou S; Yang Z; Huang W; Weng G; Chen P; Duan C; Lin Z; Wang S; Liu X; Huang Y; Zhang J; Zhang X; Li H; Ye S; Gu Y; Zhu M; Chen W; Quan W; Liu N; Chen Q; Chang Y; He J; Ji Z; Wu Y; Pan S;
    EClinicalMedicine; 2023 Nov; 65():102305. PubMed ID: 37965431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The URICO-ICTUS study, a phase 3 study of combined treatment with uric acid and rtPA administered intravenously in acute ischaemic stroke patients within the first 4.5 h of onset of symptoms.
    Amaro S; Cánovas D; Castellanos M; Gállego J; Martí-Fèbregas J; Segura T; Chamorro A
    Int J Stroke; 2010 Aug; 5(4):325-8. PubMed ID: 20636718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and Efficacy of Otaplimastat in Patients with Acute Ischemic Stroke Requiring tPA (SAFE-TPA): A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 2 Study.
    Kim JS; Lee KB; Park JH; Sung SM; Oh K; Kim EG; Chang DI; Hwang YH; Lee EJ; Kim WK; Ju C; Kim BS; Ryu JM;
    Ann Neurol; 2020 Feb; 87(2):233-245. PubMed ID: 31721277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined lysis of thrombus with ultrasound and systemic tissue plasminogen activator for emergent revascularization in acute ischemic stroke (CLOTBUST-ER): design and methodology of a multinational phase 3 trial.
    Schellinger PD; Alexandrov AV; Barreto AD; Demchuk AM; Tsivgoulis G; Kohrmann M; Alleman J; Howard V; Howard G; Alexandrov AW; Brandt G; Molina CA;
    Int J Stroke; 2015 Oct; 10(7):1141-8. PubMed ID: 26120902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intra-arterial thrombectomy versus standard intravenous thrombolysis in patients with anterior circulation stroke caused by intracranial arterial occlusions: a single-center experience.
    Sallustio F; Koch G; Di Legge S; Rossi C; Rizzato B; Napolitano S; Samà D; Arnò N; Giordano A; Tropepi D; Misaggi G; Diomedi M; Del Giudice C; Spinelli A; Fabiano S; Stefanini M; Konda D; Reale CA; Pampana E; Simonetti G; Stanzione P; Gandini R
    J Stroke Cerebrovasc Dis; 2013 Nov; 22(8):e323-31. PubMed ID: 23379980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A multicenter, randomized, double-blind, placebo-controlled trial to test efficacy and safety of magnetic resonance imaging-based thrombolysis in wake-up stroke (WAKE-UP).
    Thomalla G; Fiebach JB; Østergaard L; Pedraza S; Thijs V; Nighoghossian N; Roy P; Muir KW; Ebinger M; Cheng B; Galinovic I; Cho TH; Puig J; Boutitie F; Simonsen CZ; Endres M; Fiehler J; Gerloff C;
    Int J Stroke; 2014 Aug; 9(6):829-36. PubMed ID: 23490032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pilot study of intravenous glyburide in patients with a large ischemic stroke.
    Sheth KN; Kimberly WT; Elm JJ; Kent TA; Mandava P; Yoo AJ; Thomalla G; Campbell B; Donnan GA; Davis SM; Albers GW; Jacobson S; Simard JM; Stern BJ
    Stroke; 2014 Jan; 45(1):281-3. PubMed ID: 24193798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tenecteplase-tissue-type plasminogen activator evaluation for minor ischemic stroke with proven occlusion.
    Coutts SB; Dubuc V; Mandzia J; Kenney C; Demchuk AM; Smith EE; Subramaniam S; Goyal M; Patil S; Menon BK; Barber PA; Dowlatshahi D; Field T; Asdaghi N; Camden MC; Hill MD;
    Stroke; 2015 Mar; 46(3):769-74. PubMed ID: 25677596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Solitaire™ with the Intention for Thrombectomy as Primary Endovascular Treatment for Acute Ischemic Stroke (SWIFT PRIME) trial: protocol for a randomized, controlled, multicenter study comparing the Solitaire revascularization device with IV tPA with IV tPA alone in acute ischemic stroke.
    Saver JL; Goyal M; Bonafe A; Diener HC; Levy EI; Pereira VM; Albers GW; Cognard C; Cohen DJ; Hacke W; Jansen O; Jovin TG; Mattle HP; Nogueira RG; Siddiqui AH; Yavagal DR; Devlin TG; Lopes DK; Reddy V; du Mesnil de Rochemont R; Jahan R;
    Int J Stroke; 2015 Apr; 10(3):439-48. PubMed ID: 25777831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of thrombolysis in acute ischaemic stroke without occlusion: an observational comparative study.
    Ajili N; Decroix JP; Preda C; Labreuche J; Lopez D; Bejot Y; Michel P; Sévin-Allouet M; Sibon I; Vergnet S; Wang A; Sanda N; Mazighi M; Bourdain F; Lapergue B
    Eur J Neurol; 2016 Aug; 23(8):1380-6. PubMed ID: 27222165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase IIB/III trial of tenecteplase in acute ischemic stroke: results of a prematurely terminated randomized clinical trial.
    Haley EC; Thompson JL; Grotta JC; Lyden PD; Hemmen TG; Brown DL; Fanale C; Libman R; Kwiatkowski TG; Llinas RH; Levine SR; Johnston KC; Buchsbaum R; Levy G; Levin B;
    Stroke; 2010 Apr; 41(4):707-11. PubMed ID: 20185783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Alteplase vs Aspirin on Functional Outcome for Patients With Acute Ischemic Stroke and Minor Nondisabling Neurologic Deficits: The PRISMS Randomized Clinical Trial.
    Khatri P; Kleindorfer DO; Devlin T; Sawyer RN; Starr M; Mejilla J; Broderick J; Chatterjee A; Jauch EC; Levine SR; Romano JG; Saver JL; Vagal A; Purdon B; Devenport J; Pavlov A; Yeatts SD;
    JAMA; 2018 Jul; 320(2):156-166. PubMed ID: 29998337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemostatic activation and outcome after recombinant tissue plasminogen activator therapy for acute ischemic stroke.
    Tanne D; Macko RF; Lin Y; Tilley BC; Levine SR;
    Stroke; 2006 Jul; 37(7):1798-804. PubMed ID: 16763191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and efficacy of desmoteplase given 3-9 h after ischaemic stroke in patients with occlusion or high-grade stenosis in major cerebral arteries (DIAS-3): a double-blind, randomised, placebo-controlled phase 3 trial.
    Albers GW; von Kummer R; Truelsen T; Jensen JK; Ravn GM; Grønning BA; Chabriat H; Chang KC; Davalos AE; Ford GA; Grotta J; Kaste M; Schwamm LH; Shuaib A;
    Lancet Neurol; 2015 Jun; 14(6):575-84. PubMed ID: 25937443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute stroke management in the elderly.
    Zeevi N; Chhabra J; Silverman IE; Lee NS; McCullough LD
    Cerebrovasc Dis; 2007; 23(4):304-8. PubMed ID: 17199089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The rtPA (alteplase) 0- to 6-hour acute stroke trial, part A (A0276g) : results of a double-blind, placebo-controlled, multicenter study. Thromblytic therapy in acute ischemic stroke study investigators.
    Clark WM; Albers GW; Madden KP; Hamilton S
    Stroke; 2000 Apr; 31(4):811-6. PubMed ID: 10753980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Chemical Optimization of Cerebral Embolectomy trial: Study protocol.
    Renú A; Blasco J; Millán M; Martí-Fàbregas J; Cardona P; Oleaga L; Macho J; Molina C; Roquer J; Amaro S; Dávalos A; Zarco F; Laredo C; Tomasello A; Guimaraens L; Barranco R; Castaño C; Vivas E; Ramos A; López-Rueda A; Urra X; Muchada M; Cuadrado-Godía E; Camps-Renom P; Román LS; Ríos J; Leira EC; Jovin T; Torres F; Chamorro Á;
    Int J Stroke; 2021 Jan; 16(1):110-116. PubMed ID: 31852410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Phase III, prospective, double-blind, randomized, placebo-controlled trial of thrombolysis in imaging-eligible, late-window patients to assess the efficacy and safety of tenecteplase (TIMELESS): Rationale and design.
    Albers GW; Campbell BC; Lansberg MG; Broderick J; Butcher K; Froehler MT; Schwamm LH; Nouh AM; Liebeskind DS; Toy F; Yang M; Massaro L; Schoeffler M; Purdon B
    Int J Stroke; 2023 Feb; 18(2):237-241. PubMed ID: 35262424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rationale, design, and progress of the ENhanced Control of Hypertension ANd Thrombolysis strokE stuDy (ENCHANTED) trial: An international multicenter 2 × 2 quasi-factorial randomized controlled trial of low- vs. standard-dose rt-PA and early intensive vs. guideline-recommended blood pressure lowering in patients with acute ischaemic stroke eligible for thrombolysis treatment.
    Huang Y; Sharma VK; Robinson T; Lindley RI; Chen X; Kim JS; Lavados P; Olavarría V; Arima H; Fuentes S; Nguyen HT; Lee TH; Parsons MW; Levi C; Demchuk AM; Bath PM; Broderick JP; Donnan GA; Martins S; Pontes-Neto OM; Silva F; Pandian J; Ricci S; Stapf C; Woodward M; Wang J; Chalmers J; Anderson CS;
    Int J Stroke; 2015 Jul; 10(5):778-88. PubMed ID: 25832995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.